These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7509465)

  • 21. A role for neuropeptide Y in rat iridial arterioles.
    Newhouse MJ; Hill CE
    Am J Physiol; 1997 Nov; 273(5):H2119-27. PubMed ID: 9374743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS
    Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the Y2 receptor subtype in the regulation of prolactin gene expression by neuropeptide Y in the male rat.
    Garcia de Yebenes E; Li S; Fournier A; St-Pierre S; Pelletier G
    Neurosci Lett; 1995 May; 190(2):77-80. PubMed ID: 7644126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.
    Fuhlendorff J; Gether U; Aakerlund L; Langeland-Johansen N; Thøgersen H; Melberg SG; Olsen UB; Thastrup O; Schwartz TW
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):182-6. PubMed ID: 2153286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y produces anxiety via Y2-type receptors.
    Nakajima M; Inui A; Asakawa A; Momose K; Ueno N; Teranishi A; Baba S; Kasuga M
    Peptides; 1998; 19(2):359-63. PubMed ID: 9493869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
    Mahns DA; Kelly C; McCloskey DI; Potter EK
    J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii.
    Yang SN; Fior DR; Hedlund PB; Agnati LF; Fuxe K
    Eur J Pharmacol; 1994 Dec; 271(1):201-12. PubMed ID: 7698202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S; Corsi M; Rimland JM; Trist DG
    Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
    Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
    Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Y1 receptor activation is involved in the effect of exogenous neuropeptide Y on pup growth and the early termination of lactational diestrus in the postpartum rat.
    Toufexis DJ; Yorozu S; Woodside B
    J Neuroendocrinol; 2002 May; 14(5):354-60. PubMed ID: 12000540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
    Dumont Y; Cadieux A; Pheng LH; Fournier A; St-Pierre S; Quirion R
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):320-4. PubMed ID: 7854062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular actions of neuropeptide Y and social stress.
    Klemfuss H; Southerland S; Britton KT
    Peptides; 1998; 19(1):85-92. PubMed ID: 9437740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive effects of neuropeptide Y and related peptides in mice.
    Broqua P; Wettstein JG; Rocher MN; Gauthier-Martin B; Riviere PJ; Junien JL; Dahl SG
    Brain Res; 1996 Jun; 724(1):25-32. PubMed ID: 8816252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
    Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
    Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leu31,Pro34]neuropeptide Y (NPY), but not NPY 20-36, produces discriminative stimulus effects similar to NPY and induces food intake.
    Jewett DC; Cleary J; Schaal DW; Thompson T; Levine AS
    Brain Res; 1993 Dec; 631(1):129-32. PubMed ID: 8298985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.